These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Senescence-Associated Secretory Phenotype Suppression Mediated by Small-Sized Mesenchymal Stem Cells Delays Cellular Senescence through TLR2 and TLR5 Signaling. Kwon JH; Kim M; Um S; Lee HJ; Bae YK; Choi SJ; Hwang HH; Oh W; Jin HJ Cells; 2021 Jan; 10(1):. PubMed ID: 33401590 [TBL] [Abstract][Full Text] [Related]
5. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression. Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways. Liu YD; Ji CB; Li SB; Yan F; Gu QS; Balic JJ; Yu L; Li JK Int Immunopharmacol; 2018 Jun; 59():375-383. PubMed ID: 29689497 [TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. Yoshida H; Jono H; Kai H; Li JD J Biol Chem; 2005 Dec; 280(49):41111-21. PubMed ID: 16230348 [TBL] [Abstract][Full Text] [Related]
8. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer. West AC; Tang K; Tye H; Yu L; Deng N; Najdovska M; Lin SJ; Balic JJ; Okochi-Takada E; McGuirk P; Keogh B; McCormack W; Bhathal PS; Reilly M; Oshima M; Ushijima T; Tan P; Jenkins BJ Oncogene; 2017 Sep; 36(36):5134-5144. PubMed ID: 28481875 [TBL] [Abstract][Full Text] [Related]
9. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling. Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131 [TBL] [Abstract][Full Text] [Related]
11. IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function. Liang J; Lu F; Li B; Liu L; Zeng G; Zhou Q; Chen L Cell Cycle; 2019 Dec; 18(23):3300-3312. PubMed ID: 31594449 [TBL] [Abstract][Full Text] [Related]
13. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice. Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216 [TBL] [Abstract][Full Text] [Related]
14. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer. Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859 [TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2. Kong D; Wang Z; Tian J; Liu T; Zhou H J Cell Physiol; 2019 Apr; 234(4):4597-4607. PubMed ID: 30203548 [TBL] [Abstract][Full Text] [Related]
16. Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role. Lau L; Porciuncula A; Yu A; Iwakura Y; David G Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988157 [TBL] [Abstract][Full Text] [Related]
17. Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines. Huang Y; Cai B; Xu M; Qiu Z; Tao Y; Zhang Y; Wang J; Xu Y; Zhou Y; Yang J; Han X; Gao Q PLoS One; 2012; 7(7):e38890. PubMed ID: 22815694 [TBL] [Abstract][Full Text] [Related]
18. Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8 Xu J; Guo R; Jia J; He Y; He S BMC Immunol; 2021 Oct; 22(1):67. PubMed ID: 34620075 [TBL] [Abstract][Full Text] [Related]
19. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. Curtin JF; Liu N; Candolfi M; Xiong W; Assi H; Yagiz K; Edwards MR; Michelsen KS; Kroeger KM; Liu C; Muhammad AK; Clark MC; Arditi M; Comin-Anduix B; Ribas A; Lowenstein PR; Castro MG PLoS Med; 2009 Jan; 6(1):e10. PubMed ID: 19143470 [TBL] [Abstract][Full Text] [Related]